Ms. Holmes is accused of misleading investors in her company, Theranos. Opening statements in the case will start next week.
Jury selection began on Tuesday in the long-awaited trial of Elizabeth Holmes, the disgraced founder of the blood testing start-up Theranos, who faces a dozen counts of fraud and conspiracy to commit wire fraud. Ms. Holmes, wearing a medical mask and navy blue skirt suit, with lawyers at her side, was immediately swarmed by a scrum of photographers on her arrival at the federal courthouse in San Jose, Calif. Inside the courtroom, she watched as Judge Edward Davila of U.S. District Court for the Northern District of California, who is overseeing the case, and the lawyers questioned the panel of potential jurors, who were winnowed down from a list of more than 200 to around 50. The jurors sat in assigned seats that were spaced apart for the pandemic. At the heart of the trial are questions of what exactly Ms. Holmes,37, knew of the problems with Theranos’s blood-testing devices and whether she intentionally misled investors over the company’s technology.
